Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 781-792 of 4,306
Drug study icon
CompletedEUCTR 2014-000520-14

Prednisolone addition for atients with recent onset psychotic disorder: the role of immune-modulating strategies in the treatment of psychosis.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.
Countries
Belgium, Netherlands
Sponsor
University Medical Center Utrecht
Condition
Schizophrenia
Device study icon
CompletedNCT04038788

Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Taipei
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 20 Years to 65 Years
Countries
Taiwan
Sponsor
Tri-Service General Hospital (TSGH)
Condition
Schizophrenia
Drug study icon
TerminatedNCT00169026

Alcoholism and Schizophrenia: Effects of Clozapine

This summary needs review. Please check the official study record and contact the research team for details.

In Jamaica Plain
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 19 Years to 65 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Schizophrenia
Drug study icon
CompletedNCT00946348

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In Lebanon
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, AddictionDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Schizophrenia, Addiction
Other study type icon
CompletedNCT00119574

Evaluating a Collaborative Care Model for Schizophrenia (EQUIP)

This summary needs review. Please check the official study record and contact the research team for details.

In West Los Angeles
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
US Department of Veterans Affairs
Condition
Schizophrenia
Other study type icon
TerminatedNCT00001198

Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 6 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
Drug study icon
CompletedNCT00412373

Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in people with Schizoaffective Disorder.

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Cerritos
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, India, Malaysia, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00407277

Neural Inhibition as a Mechanism of Addiction Among Persons With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, AddictionBehavioralFrom 18 Years to 60 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia, Addiction
Drug study icon
TerminatedNCT02949232

Prednisolone Addition for people with Recent-onset Psychotic Disorder

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Antwerp
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
Belgium, Denmark, Netherlands
Sponsor
UMC Utrecht
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.